(Q44970615)

7 December 2017

title

Diabetes mellitus, oxidative stress and advanced glycation endproducts (English)

1 reference

7 December 2017

author name string

D Bonnefont-Rousselot

1

1 reference

7 December 2017

J-L Beaudeux

2

1 reference

7 December 2017

P Thérond

3

1 reference

7 December 2017

J Peynet

4

1 reference

7 December 2017

A Legrand

5

1 reference

7 December 2017

J Delattre

6

1 reference

7 December 2017

language of work or name

French

0 references

publication date

1 May 2004

1 reference

Annales pharmaceutiques françaises

7 December 2017

published in

1 reference

7 December 2017

volume

62

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

147-157

1 reference

Glucose and reactive oxygen species

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Antioxidants, diabetes and endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

What is oxidative stress?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Serum markers of oxidative stress and severity of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Metabolic control quality and free radical activity in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Oxidative markers in diabetic ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Lipid peroxidation and antioxidant enzyme activities in patients with type 1 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Oxidative protein damage in plasma of type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Oxidative protein damage in type I diabetic patients with and without complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Oxidative damage to DNA in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Zinc in relation to diabetes and oxidative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Total Plasma Antioxidant Capacity Predicts Thrombosis-Prone Status in NIDDM Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Depletion of total antioxidant capacity in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Protein kinase C activation and the development of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

NADPH oxidase: a universal oxygen sensor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Molecular aspects of lipoic acid in the prevention of diabetes complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Advanced glycation end-products: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Overexpression of the aldose reductase gene induces apoptosis in pancreatic beta-cells by causing a redox imbalance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Oxidative stress and glycemic regulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Mutual interaction between glycation and oxidation during non-enzymatic protein modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Antioxidant and anti-AGE therapeutics: evaluation and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4509%2804%2994297-6

10.1016/S0003-4509(04)94297-6

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference